If you need more lookups,
subscriptions start at $34 USD/month.
Rong Wang Location
Phoenix, AZ, US
Rong Wang Work
2024 -now President and CEO @
2024 -2024 President and Chief Operating Officer @
2021 -2024 Chief Operating and Financial Officer @
2021 -now Founder @ Banyanbaum LLC
2014 -now Volunteer and Mentor and Officer and Business Advisor @ Various Life Science and Technology Organizations
2019 -2021 Corporate Officer and Secretary and Chief Financial Officer @ Tiempo Development - Acquired by 3Pillar Global
2015 -2019 Corporate Officer and Secretary and Vice President @ MID Labs Inc. - Acquired by Hoya Corp (HOCPF)
2013 -2014 Director of Finance Operations @ Abaxis - Acquired by Zoetis (ZTS)
2012 -2013 Director of Finance @
2007 -2012 Sr. Manager - Capital and International Management and Operations and Business Partnership @
2005 -2007 Manager - Capital Market and Financial Risk Management @
2003 -2005 Sr. Analyst - Office of CFO @ Federal-Mogul - Acquired by Tenneco (TEN)
Rong Wang Education
University of Michigan - Stephen M. Ross School of Business
MBA
2002
University of Michigan
MSE (Industrial Engineering)
1998
Tsinghua University
BS (Engineering)
1996
Rong Wang Skills
General Management
Strategy
Finance
Project Management
Capital Markets
Corporate Governance
Mergers & Acquisitions (M&A)
Corporate Development
Venture Capital
Private Equity
Human Resources (HR)
Leadership
Organizational Development
Executive Management
Stakeholder Management
Rong Wang Summary
Rong Wang, based in Phoenix, AZ, US, is currently a President and CEO at NuvOx Therapeutics. Rong Wang brings experience from previous roles at NuvOx Pharma, Banyanbaum LLC and Various Life Science and Technology Organizations. Rong Wang holds a MBA @ University of Michigan - Stephen M. Ross School of Business. With a robust skill set that includes General Management, Strategy, Finance, Project Management, Capital Markets and more. Rong Wang has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Rong Wang?
Find contact details for 700 million professionals.